本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NovoCure Limited

12.19
-0.1400-1.14%
盘后12.190.00000.00%16:36 EDT
成交量:120.31万
成交额:1,478.75万
市值:13.63亿
市盈率:-7.81
高:12.50
开:12.29
低:12.12
收:12.33
52周最高:34.13
52周最低:10.87
股本:1.12亿
流通股本:9,414.79万
量比:0.94
换手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-1.5604
每股收益(LYR):-1.5638
净资产收益率:-48.07%
总资产收益率:-8.64%
市净率:3.90
市盈率(LYR):-7.80

数据加载中...

2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/09

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/28

重要事件披露

Form 8-K - Current report
2023/10/26

重要事件披露

Form 8-K - Current report